Waddell & Reed Financial’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | $54.3M | Sell |
1,216,636
-861,664
| -41% | -$38.4M | 0.11% | 217 |
|
|
2020
Q4 | $95.6M | Buy |
2,078,300
+169,070
| +9% | +$7.78M | 0.2% | 138 |
|
|
2020
Q3 | $89.8M | Sell |
1,909,230
-177,473
| -9% | -$8.35M | 0.22% | 128 |
|
|
2020
Q2 | $106M | Sell |
2,086,703
-95,387
| -4% | -$4.86M | 0.28% | 100 |
|
|
2020
Q1 | $103M | Sell |
2,182,090
-55,009
| -2% | -$2.61M | 0.34% | 81 |
|
|
2019
Q4 | $131M | Buy |
2,237,099
+731,351
| +49% | +$43M | 0.33% | 86 |
|
|
2019
Q3 | $80.3M | Buy |
+1,505,748
| New | +$80.3M | 0.21% | 139 |
|
|
2016
Q1 | – | Sell |
-791,777
| Closed | -$39.9M | – | 604 |
|
|
2015
Q4 | $39.9M | Sell |
791,777
-549,223
| -41% | -$27.7M | 0.06% | 232 |
|
|
2015
Q3 | $64.5M | Sell |
1,341,000
-189,640
| -12% | -$9.11M | 0.11% | 191 |
|
|
2015
Q2 | $79.7M | Buy |
1,530,640
+65,680
| +4% | +$3.42M | 0.11% | 189 |
|
|
2015
Q1 | $84.5M | Sell |
1,464,960
-3,510,904
| -71% | -$203M | 0.12% | 193 |
|
|
2014
Q4 | $266M | Buy |
4,975,864
+4,252,424
| +588% | +$227M | 0.37% | 82 |
|
|
2014
Q3 | $41.6M | Sell |
723,440
-379,600
| -34% | -$21.8M | 0.06% | 240 |
|
|
2014
Q2 | $73.7M | Buy |
1,103,040
+55,840
| +5% | +$3.73M | 0.11% | 195 |
|
|
2014
Q1 | $69.9M | Buy |
1,047,200
+24,400
| +2% | +$1.63M | 0.11% | 192 |
|
|
2013
Q4 | $68.3M | Buy |
1,022,800
+41,360
| +4% | +$2.76M | 0.11% | 194 |
|
|
2013
Q3 | $61.5M | Buy |
981,440
+66,760
| +7% | +$4.19M | 0.12% | 186 |
|
|
2013
Q2 | $57.1M | Buy |
+914,680
| New | +$57.1M | 0.12% | 186 |
|